Your browser doesn't support javascript.
loading
Description of pathogenic bacteria in patients with respiratory symptoms associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Colombia.
Zuluaga, Nathalia; Martínez, David; Hernández, Carolina; Ballesteros, Nathalia; Castañeda, Sergio; Ramírez, Juan David; Muñoz, Marina.
Afiliação
  • Zuluaga N; Centro de Investigaciones en Microbiología and Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia.
  • Martínez D; Centro de Investigaciones en Microbiología and Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia.
  • Hernández C; Centro de Investigaciones en Microbiología and Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia.
  • Ballesteros N; Centro de Tecnología en Salud (CETESA), Innovaseq SAS, Bogotá, Colombia.
  • Castañeda S; Centro de Investigaciones en Microbiología and Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia.
  • Ramírez JD; Centro de Investigaciones en Microbiología and Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia.
  • Muñoz M; Centro de Investigaciones en Microbiología and Biotecnología-UR (CIMBIUR), Facultad de Ciencias Naturales, Universidad del Rosario, Bogotá, Colombia.
Ann Clin Microbiol Antimicrob ; 22(1): 56, 2023 Jul 07.
Article em En | MEDLINE | ID: mdl-37420198
ABSTRACT
Viral respiratory infections may predispose to co-infections with other pathogenic microorganisms. In this study, pathogenic respiratory bacteria were detected using commercial kit Allplex™ Respiratory Panel 4 from nasopharyngeal samples from individuals suffering respiratory symptoms with and without severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients without respiratory symptoms were included as controls. Haemophilus influenzae and Streptococcus pneumoniae were detected from 12 patients (6%) in both, patients with respiratory symptoms (including hospitalized) (n = 6) and individual without symptoms (n = 6). Pathogenic bacteria possibly proliferate due to the limited immune response of patients with SARS-CoV-2, perhaps due to dysbiosis generated by the viral infection.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia / COVID-19 Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do sul / Colombia Idioma: En Revista: Ann Clin Microbiol Antimicrob Assunto da revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Colômbia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia / COVID-19 Tipo de estudo: Diagnostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: America do sul / Colombia Idioma: En Revista: Ann Clin Microbiol Antimicrob Assunto da revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Colômbia